O papel do enfermeiro oncologista na otimização da jornada da pessoa com cancro da mama avançado
DOI:
https://doi.org/10.31877/on.2024.49.02Palavras-chave:
Cancro da mama avançado, Enfermeiro, Jornada do doente, Multidisciplinaridade, Qualidade de vida relacionada com a saúdeResumo
O cancro da mama é o tipo de cancro mais comum nas mulheres globalmente e foi o segundo mais comum em Portugal em 2020. A doença avançada é a principal causa de morte e a fase da doença que requer mais cuidados, mas várias necessidades subsistem na jornada dos doentes. Um grupo de peritos reuniu-se para identificar as principais necessidades destes doentes ao longo da sua jornada, lacunas nas mesmas nas instituições portuguesas e como as suprir de modo a otimizar o contínuo de cuidados e consequentemente os resultados em saúde com qualidade de vida.
Foram considerados quatro momentos chave da jornada do doente − diagnóstico, primeira linha de tratamento, monitorização e linhas avançadas de tratamento e posteriormente – e, em cada um, proposto um conjunto de linhas de ação no âmbito da Enfermagem com potencial para otimizar a abordagem à pessoa com cancro da mama avançado em Portugal.
Downloads
Referências
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 2021; 71: 209–49.
International Agency for Research on Cancer WHO. GLOBOCAN 2020 - Portugal Fact Sheet. https://gco.iarc.fr/today/data/factsheets/populations/620-portugal-fact-sheets.pdf. 2021. Available from: https://gco.iarc.fr/today/data/factsheets/populations/620-portugal-fact-sheets.pdf.
Cardoso F, Spence D, Mertz S, et al. Global analysis of advanced/metastatic breast cancer: Decade report (2005–2015). The Breast 2018; 39: 131–8.
Howlader, N; Noone, AM; Krapcho, M; et al. SEER Cancer Statistics Review, 1975-2013, National Cancer Institute. Based on November 2015 SEER Data Submission. Bethesda. Available from: https//seer.cancer.gov/archive/csr/1975_2013/. Accessed July 10, 2020. 2016.
Cardoso F, Paluch-Shimon S, Senkus E, et al. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5). Ann Oncol 2020; 31: 1623–49.
Mayer M, Grober SE. Silent Voices: Women with Advanced (Metastatic) Breast Cancer Share Their Needs and Preferences for Information, Support and Practical Resources. White Pap. Living Beyond Breast Cancer. 2006. Available from:https://www.researchgate.net/publication/274510595_Silent_Voices_Women_with_Advanced_Metastatic_Breast_Cancer_Share_Their_Needs_and_Preferences_for_Information_Support_and_Practical_Resources.
Au A, Lam W, Tsang J, et al. Supportive care needs in Hong Kong Chinese women confronting advanced breast cancer. Psychooncology 2013; 22: 1144–51.
Ecclestone C, Chow R, Pulenzas N, et al. Quality of life and symptom burden in patients with metastatic breast cancer. Support Care Cancer 2016; 24: 4035–43.
Kadravello A, Tan S-B, Ho G-F, Kaur R, Yip C-H. Exploring Unmet Needs from an Online Metastatic Breast Cancer Support Group: A Qualitative Study. Medicina (B Aires) 2021; 57: 693.
Reed E, Simmonds P, Haviland J, Corner J. Quality of Life and Experience of Care in Women With Metastatic Breast Cancer: A Cross-Sectional Survey. J Pain Symptom Manage 2012; 43: 747–58.
Uchida M, Akechi T, Okuyama T, et al. Patients’ Supportive Care Needs and Psychological Distress in Advanced Breast Cancer Patients in Japan. Jpn J Clin Oncol 2011; 41: 530–6.
Demicheli R, Biganzoli E, Boracchi P, Greco M, Retsky MW. Recurrence dynamics does not depend on the recurrence site. Breast Cancer Res 2008; 10: R83.
Retsky M, Demicheli R, Hrushesky WJM. Does surgery induce angiogenesis in breast cancer? Indirect evidence from relapse pattern and mammography paradox. Int J Surg 2005; 3: 179–87.
Cardoso F, Kyriakides S, Ohno S, et al. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2019; 30: 1194–220.
Runowicz CD, Leach CR, Henry NL, et al. American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. J Clin Oncol 2016; 34: 611–35.
Fallowfield L, Boyle FM, Travado L, et al. Gaps in Care and Support for Patients With Advanced Breast Cancer: A Report From the Advanced Breast Cancer Global Alliance. JCO Glob Oncol 2021; : 976–84.
van Egdom LSE, Oemrawsingh A, Verweij LM, et al. Implementing Patient-Reported Outcome Measures in Clinical Breast Cancer Care: A Systematic Review. Value Heal 2019; 22: 1197–226.
U.S. Food and Drug Administration. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims - Guidance for Industry. 2009. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/patient-reported-outcome-measures-use-medical-product-development-support-labeling-claims.
Porter I, Gonçalves-Bradley D, Ricci-Cabello I, et al. Framework and guidance for implementing patient-reported outcomes in clinical practice: evidence, challenges and opportunities. J Comp Eff Res 2016; 5: 507–19.
Ghislain I, Zikos E, Coens C, et al. Health-related quality of life in locally advanced and metastatic breast cancer: methodological and clinical issues in randomised controlled trials. Lancet Oncol 2016; 17: e294–304.
Pe M, Dorme L, Coens C, et al. Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review. Lancet Oncol 2018; 19: e459–69.
REED E, KÖSSLER I, HAWTHORN J. Quality of life assessments in advanced breast cancer: should there be more consistency? Eur J Cancer Care (Engl) 2012; 21: 565–80.
Burguin A, Diorio C, Durocher F. Breast Cancer Treatments: Updates and New Challenges. J Pers Med 2021; 11: 808.
Mierzynska J, Piccinin C, Pe M, et al. Prognostic value of patient-reported outcomes from international
randomised clinical trials on cancer: a systematic review. Lancet Oncol 2019; 20: e685–98.
Jordan K, Aapro M, Kaasa S, et al. European Society for Medical Oncology (ESMO) position paper on supportive and palliative care. Ann Oncol 2018; 29: 36–43.
Modi ND, Danell NO, Perry RNA, et al. Patient-reported outcomes predict survival and adverse events following anticancer treatment initiation in advanced HER2-positive breast cancer. ESMO Open 2022; 7: 100475.
Coelho A, Kendir C, Barrenho E, et al. Patient-Reported Outcomes and Experiences Assessment in Women with Breast Cancer: Portuguese Case Study. Int J Environ Res Public Health 2023; 20: 2931.
Ong WL, Schouwenburg MG, van Bommel ACM, et al. A Standard Set of Value-Based Patient-Centered Outcomes for Breast Cancer. JAMA Oncol 2017; 3: 677.
Bochenek-Cibor J, Górecka M, Storman D, Bała MM. Support for Metastatic Breast Cancer Patients—a Systematic Review. J Cancer Educ 2020; 35: 1061–7.
Breast Cancer Now. The Unsurvivors report. 2019 Available from: https://breastcancernow.org/sites/default/files/bcn_theunsurvivors_campaignreport_oct2019.pdf.
Vila C, Reñones C, Ferro T, et al. Advanced breast cancer clinical nursing curriculum: review and recommendations. Clin Transl Oncol 2017; 19: 251–60.
Eicher M, Kadmon I, Claassen S, et al. Training breast care nurses throughout Europe: The EONS postbasic curriculum for breast cancer nursing. Eur J Cancer 2012; 48: 1257–62.
Vieira C, Almeida D, Almeida M, Almeida SS, Amarelo A, Amorim AP, et al. MAAT (Multidisciplinary Approach in ABC Treatment) – Jornada do Doente com Cancro da Mama Avançado – Consenso Multidisciplinar para Otimizar os Padrões de Cuidados em Portugal. 2023. Available from: https://www.novartis.com/pt-pt/stories/uma-estrategia-multidisciplinar-para-melhorar-vida-das-pessoas-com-cancro-da-mama-metastático
National Comprehensive Cancer Network. NCCN Guidelines, versão 2.2022 - Gestão de angústia. Available from: https://www.nccn.org/professionals/physician_gls/pdf/distress_tool_portuguese.pdf. 2022. https://www.nccn.org/professionals/physician_gls/pdf/distress_tool_portuguese.pdf.
U.S. Department of Health and Human Services, National Institutes of Health NCI. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. Available from: https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_5x7.pdf. 2017.
Brown T, Cruickshank S, Noblet M. Specialist breast care nurses for support of women with breast cancer. Cochrane Database Syst Rev 2021; 2(2):CD005634.
Decoster L, Van Puyvelde K, Mohile S, et al. Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations. Ann Oncol 2015; 26: 288–300.
Kenis C, Decoster L, Van Puyvelde K, et al. Performance of Two Geriatric Screening Tools in Older Patients With Cancer. J Clin Oncol 2014; 32: 19–26.
Zhang YH, Xie FY, Chen YW, et al. Evaluating the Nutritional Status of Oncology Patients and Its Association with Quality of Life. Biomed Environ Sci 2018; 31: 637–44.
Harvey C, Palmer J, Hegney D, et al. The evaluation of nurse navigators in chronic and complex care. J Adv Nurs 2019; : jan.14041.
McMullen L. Oncology Nurse Navigators and the Continuum of Cancer Care. Semin Oncol Nurs 2013; 29: 105–17.
Byrne A, Harvey C, Baldwin A. Nurse navigators and person‐centred care; delivered but not valued? Nurs Inq 2021; 28. DOI:10.1111/nin.12402.
Byrne A, Hegney D, Harvey C, et al. Exploring the nurse navigator role: A thematic analysis. J Nurs Manag 2020; 28: 814–21.
Pautasso FF, Zelmanowicz A de M, Flores CD, Caregnato RCA. Atuação do Nurse Navigator: revisão integrativa. Rev Gaúcha Enferm 2018; 39:e20170102.
SNS 24. Testamento Vital. 2023 Available from: https://www.sns24.gov.pt/servico/testamento-vital/.
Campbell KL, WINTERS-STONE KM, WISKEMANN J, et al. Exercise Guidelines for Cancer Survivors: Consensus Statement from International Multidisciplinary Roundtable. Med Sci Sport Exerc 2019; 51: 2375–90.
Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983; 67: 361–70.
Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology. JNCI J Natl Cancer Inst 1993; 85: 365–76.
Bjelic-Radisic V, Cardoso F, Cameron D, et al. An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: EORTC QLQ-BR45. Ann Oncol 2020; 31: 283–8.
Pusic AL, Klassen AF, Scott AM, Klok JA, Cordeiro PG, Cano SJ. Development of a New Patient-Reported Outcome Measure for Breast Surgery: The BREAST-Q. Plast Reconstr Surg 2009; 124: 345–53.
Pusic, Andrea L.; Klassen, Anne; Cano S. BREAST-Q Version 2.0© - A Guide for Researchers and Clinicians. 2017. Available from: https://qportfolio.org/wp-content/uploads/2018/12/BREAST-Q-USERS-GUIDE.pdf.
Downloads
Publicado
Como Citar
Edição
Secção
Licença
Direitos de Autor (c) 2024 Joana Cavaco-Silva, Vanessa Leomaro, Anabela Amarelo, Cristina Madeira, Patrícia Rosa, Ana Paula Amorim
Este trabalho encontra-se publicado com a Licença Internacional Creative Commons Atribuição-NãoComercial-CompartilhaIgual 4.0.
(CINAHL Ultimate database)
